We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Virtual Microscopy System Makes Slides Accessible Everywhere

By Labmedica staff writers
Posted on 04 Aug 2008
A virtual microscopy system offers new features to enable users to quickly and easily examine slides without being near a microscope.

The dotSlide workstation and server system are equipped for optimal speed, precision, security, and performance and enable fully controllable remote access, whatever the requirements. More...
Data and associated meta-data are saved in a data management system so that slides can be scanned in one location and reviewed almost instantaneously in another, by users anywhere in the world via a web browser.

The dotSlide system features a robotic arm that places the slides onto a stage holder and an integrated barcode scanner that ensures that any bar-coded metadata are automatically loaded and linked with the resultant virtual image.

All dotSlide models use the advanced Olympus (Hamburg, Germany) BX51 microscope, which offers excellent optical performance. The standard dotSlide MD system is fluorescent-compatible, allowing slides and metadata to be loaded manually and the virtual file created automatically based on the user's preferences. With dotSlide SL, slides are automatically loaded from the slide loader, which holds up to 50 slides in five trays. The dotSlide TMA is a complete system incorporating a tissue microarray (TMA) module with the new client-server database Net Image Server (NIS) SQL.

This combination facilitates the acquisition of small tissue cores as single images, which are then immediately uploaded together with the relevant metadata and overview of the TMA slide to the NIS SQL database for traceability.

The newest Olympus dotSlide 2.0 offers additional innovative functions and is even easier to use. The user is guided through the virtual slide acquisition process step-by-step by an intuitive Scan Wizard. This graphical user interface (GUI) features large control icons and allows inexperienced users to produce perfect image results with minimal training. The system is capable of scanning multiple large specimens in up to 15 Z-planes. Virtual Z allows the reviewer to simply focus through the specimen, as well as to examine regions of interest in different dimensions. The system enables better observation for remote consults, as well as consistent training for students and pathologists.


Related Links:
Olympus

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Electrolyte Analyzer
BKE-B
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.